Fig. 8
Cell viability of (A) SW-872 cancer cells after treatment with LMn for 24 and 48 h, (B) SW-872 cancer cells after treatment with LZn for 24 and 48 h, (C) HFF-2 normal cells after treatment with LMn for 24 and 48 h, (D) HFF-2 normal cells after treatment with LZn for 24 and 48 h. * indicate a significant difference compared to the control group (*P value < 0.05, **P value < 0.01, ***P value < 0.001).
